Sherine Gabriel

Summary

Affiliation: Mayo Clinic
Country: USA

Publications

  1. ncbi request reprint The epidemiology of rheumatoid arthritis
    S E Gabriel
    Departments of Health Sciences Research and Internal Medicine, Division of Rheumatology, Mayo Foundation, Rochester, Minnesota, USA
    Rheum Dis Clin North Am 27:269-81. 2001
  2. ncbi request reprint Comorbidity in arthritis
    S E Gabriel
    Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota 55905, USA
    J Rheumatol 26:2475-9. 1999
  3. ncbi request reprint Direct medical costs attributable to osteoporotic fractures
    S E Gabriel
    Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota 55905, USA
    Osteoporos Int 13:323-30. 2002
  4. pmc Why do people with rheumatoid arthritis still die prematurely?
    S E Gabriel
    Department of Health Sciences Research, Mayo Foundation, Rochester, MN 55905, USA
    Ann Rheum Dis 67:iii30-4. 2008
  5. ncbi request reprint Survival in rheumatoid arthritis: a population-based analysis of trends over 40 years
    Sherine E Gabriel
    Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota 55905, USA
    Arthritis Rheum 48:54-8. 2003
  6. pmc Progress towards an OMERACT-ILAR guideline for economic evaluations in rheumatology
    S E Gabriel
    Department of Health Sciences Research and Division of Rheumatology, Mayo Clinic, Rochester, MN 55905, USA
    Ann Rheum Dis 61:370-3. 2002
  7. pmc Epidemiological studies in incidence, prevalence, mortality, and comorbidity of the rheumatic diseases
    Sherine E Gabriel
    Department of Health Sciences Research, Mayo Foundation, Rochester, MN 55905, USA
    Arthritis Res Ther 11:229. 2009
  8. doi request reprint Heart disease and rheumatoid arthritis: understanding the risks
    S E Gabriel
    Mayo Clinic, Rochester, MN, USA
    Ann Rheum Dis 69:i61-64. 2010
  9. ncbi request reprint A clinical and economic review of disease-modifying antirheumatic drugs
    S E Gabriel
    Health Sciences Research, Mayo Foundation, Rochester, Minnesota 55905, USA
    Pharmacoeconomics 19:715-28. 2001
  10. ncbi request reprint A comparison of two comorbidity instruments in arthritis
    S E Gabriel
    Department of Health Sciences Research, Mayo Foundation, Rochester, Minnesota 55905, USA
    J Clin Epidemiol 52:1137-42. 1999

Research Grants

  1. HEART DISEASE IN RHEUMATOID ARTHRITIS
    Sherine Gabriel; Fiscal Year: 2004
  2. HEART DISEASE IN RHEUMATOID ARTHRITIS
    Sherine E Gabriel; Fiscal Year: 2010
  3. HEART DISEASE IN RHEUMATOID ARTHRITIS
    Sherine Gabriel; Fiscal Year: 2007
  4. HEART DISEASE IN RHEUMATOID ARTHRITIS
    Sherine Gabriel; Fiscal Year: 2009

Detail Information

Publications84

  1. ncbi request reprint The epidemiology of rheumatoid arthritis
    S E Gabriel
    Departments of Health Sciences Research and Internal Medicine, Division of Rheumatology, Mayo Foundation, Rochester, Minnesota, USA
    Rheum Dis Clin North Am 27:269-81. 2001
    ..These include genetics, infectious agents, oral contraceptives, smoking, and formal education. Epidemiologic research is an essential contributor to our understanding of RA...
  2. ncbi request reprint Comorbidity in arthritis
    S E Gabriel
    Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota 55905, USA
    J Rheumatol 26:2475-9. 1999
    ..To describe the relative frequency of selected comorbidities in 2 population based prevalence cohorts of patients with rheumatoid arthritis (RA) and osteoarthritis (OA) compared to age and sex matched community controls...
  3. ncbi request reprint Direct medical costs attributable to osteoporotic fractures
    S E Gabriel
    Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota 55905, USA
    Osteoporos Int 13:323-30. 2002
    ..The use of incremental costs in economic analyses will provide a more accurate reflection of the true cost-effectiveness of osteoporosis prevention...
  4. pmc Why do people with rheumatoid arthritis still die prematurely?
    S E Gabriel
    Department of Health Sciences Research, Mayo Foundation, Rochester, MN 55905, USA
    Ann Rheum Dis 67:iii30-4. 2008
    ..Together, these results provide a compelling argument in favour of a focused research programme aimed specifically at eliminating premature death in patients with RA...
  5. ncbi request reprint Survival in rheumatoid arthritis: a population-based analysis of trends over 40 years
    Sherine E Gabriel
    Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota 55905, USA
    Arthritis Rheum 48:54-8. 2003
    ..To evaluate trends in and risk factors for mortality among patients with rheumatoid arthritis (RA) over a 40-year period...
  6. pmc Progress towards an OMERACT-ILAR guideline for economic evaluations in rheumatology
    S E Gabriel
    Department of Health Sciences Research and Division of Rheumatology, Mayo Clinic, Rochester, MN 55905, USA
    Ann Rheum Dis 61:370-3. 2002
    ..Preliminary recommendations for "reference cases" in osteoporosis, rheumatoid arthritis, and osteoarthritis are proposed...
  7. pmc Epidemiological studies in incidence, prevalence, mortality, and comorbidity of the rheumatic diseases
    Sherine E Gabriel
    Department of Health Sciences Research, Mayo Foundation, Rochester, MN 55905, USA
    Arthritis Res Ther 11:229. 2009
    ..Taken together, these findings underscore the complexity of the rheumatic diseases and highlight the key role of epidemiological research in understanding these intriguing conditions...
  8. doi request reprint Heart disease and rheumatoid arthritis: understanding the risks
    S E Gabriel
    Mayo Clinic, Rochester, MN, USA
    Ann Rheum Dis 69:i61-64. 2010
    ..RA-specific cardiovascular risk prediction tools are needed, as well as clinical trials to assess the impact of therapies and tight control of inflammation in RA patients on cardiovascular outcomes and mortality...
  9. ncbi request reprint A clinical and economic review of disease-modifying antirheumatic drugs
    S E Gabriel
    Health Sciences Research, Mayo Foundation, Rochester, Minnesota 55905, USA
    Pharmacoeconomics 19:715-28. 2001
    ....
  10. ncbi request reprint A comparison of two comorbidity instruments in arthritis
    S E Gabriel
    Department of Health Sciences Research, Mayo Foundation, Rochester, Minnesota 55905, USA
    J Clin Epidemiol 52:1137-42. 1999
    ....
  11. ncbi request reprint Change in diagnosis among orthopedists compared to non-orthopedists in the management of acute knee injuries
    S E Gabriel
    Department of Health Sciences Research, Mayo Clinic and Foundation, Rochester, Minnesota, USA
    J Rheumatol 27:2412-7. 2000
    ..We sought to compare change in diagnosis among orthopedists and non-orthopedists caring for a community based cohort of individuals with incident acute knee injuries...
  12. pmc Is the incidence of rheumatoid arthritis rising?: results from Olmsted County, Minnesota, 1955-2007
    Elena Myasoedova
    Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA
    Arthritis Rheum 62:1576-82. 2010
    ..To examine trends in the incidence and prevalence of rheumatoid arthritis (RA) from 1995 to 2007...
  13. pmc High ten-year risk of cardiovascular disease in newly diagnosed rheumatoid arthritis patients: a population-based cohort study
    Hilal Maradit Kremers
    Mayo Clinic, Rochester, MN 55905, USA
    Arthritis Rheum 58:2268-74. 2008
    ..To estimate the 10-year absolute risk of cardiovascular (CV) events in newly diagnosed rheumatoid arthritis (RA) patients and the potential contribution of CV risk factors to absolute risk assessment...
  14. ncbi request reprint Trends in incidence and mortality in rheumatoid arthritis in Rochester, Minnesota, over a forty-year period
    Michele F Doran
    Mayo Clinic, Rochester, Minnesota 55905, USA
    Arthritis Rheum 46:625-31. 2002
    ..To determine time trends in the epidemiology of rheumatoid arthritis (RA) in a population-based cohort...
  15. pmc Trends in incidence of adult-onset psoriasis over three decades: a population-based study
    Murat Icen
    Department of Health Sciences Research, College of Medicine, Mayo Clinic, Rochester, Minnesota 55905, USA
    J Am Acad Dermatol 60:394-401. 2009
    ..The objective of this study is to determine time trends in incidence and survival of psoriasis patients over three decades...
  16. ncbi request reprint Cardiovascular death in rheumatoid arthritis: a population-based study
    Hilal Maradit-Kremers
    Mayo Clinic, Rochester, Minnesota 55905, USA
    Arthritis Rheum 52:722-32. 2005
    ..To determine whether systemic inflammation confers any additional risk for cardiovascular death among patients with rheumatoid arthritis (RA), after adjusting for traditional cardiovascular risk factors and comorbidities...
  17. ncbi request reprint Therapeutic strategies in rheumatoid arthritis over a 40-year period
    Hilal Maradit Kremers
    Department of Health Sciences Research, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
    J Rheumatol 31:2366-73. 2004
    ....
  18. ncbi request reprint The widening mortality gap between rheumatoid arthritis patients and the general population
    Angel Gonzalez
    Mayo Clinic, Rochester, Minnesota, USA
    Arthritis Rheum 56:3583-7. 2007
    ..The purpose of this study was to determine the mortality trends among RA patients compared with those in the general population...
  19. ncbi request reprint Glucocorticoids and cardiovascular and cerebrovascular events in polymyalgia rheumatica
    Hilal Maradit Kremers
    Mayo Clinic, Rochester, Minnesota 55905, USA
    Arthritis Rheum 57:279-86. 2007
    ..To examine the effect of glucocorticoid use on the risk of various cardiovascular diseases in patients with polymyalgia rheumatica (PMR)...
  20. doi request reprint Cardiovascular disease in rheumatoid arthritis: a step forward
    Elena Myasoedova
    Mayo Clinic, Rochester, Minnesota, USA
    Curr Opin Rheumatol 22:342-7. 2010
    ..The present review highlights the recent findings on cardiovascular disease in rheumatoid arthritis (RA), and outlines the current concepts and prospects of cardiovascular disease detection and management in RA...
  21. ncbi request reprint Prognostic importance of low body mass index in relation to cardiovascular mortality in rheumatoid arthritis
    Hilal Maradit Kremers
    Department of Health Sciences Research, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
    Arthritis Rheum 50:3450-7. 2004
    ..This study compared the effect of BMI on cardiovascular mortality in a population-based cohort of subjects with RA with that in a cohort of individuals without RA from the same population...
  22. pmc Incidence and clinical predictors of psoriatic arthritis in patients with psoriasis: a population-based study
    Floranne C Wilson
    The Mayo Clinic, College of Medicine, Rochester, Minnesota 55905, USA
    Arthritis Rheum 61:233-9. 2009
    ..To determine the incidence and disease-specific predictors of clinically recognized psoriatic arthritis (PsA) in patients with psoriasis...
  23. pmc The presentation and outcome of heart failure in patients with rheumatoid arthritis differs from that in the general population
    John M Davis
    Mayo Clinic, Rochester, Minnesota, USA
    Arthritis Rheum 58:2603-11. 2008
    ..To compare the clinical presentation, management, and outcome of heart failure in patients with rheumatoid arthritis (RA) compared with non-RA patients...
  24. pmc Time trends in epidemiology and characteristics of psoriatic arthritis over 3 decades: a population-based study
    Floranne C Wilson
    Division of Rheumatology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
    J Rheumatol 36:361-7. 2009
    ..To determine time trends in incidence, prevalence, and clinical characteristics of psoriatic arthritis (PsA) over a 30-year period...
  25. ncbi request reprint Heart disease in psoriasis
    Hilal Maradit Kremers
    Division of Epidemiology, Department of Health Sciences Research, Mayo Clinic, Rochester, MN 55905, USA
    J Am Acad Dermatol 57:347-54. 2007
    ..This review summarizes the current evidence for an increased cardiovascular risk in patients with psoriasis and outlines deficits in our knowledge in this area...
  26. ncbi request reprint Mortality, disability, and nursing home use for persons with and without hip fracture: a population-based study
    Cynthia L Leibson
    Department of Health Sciences Research, Mayo Clinic and Foundation, Rochester, Minnesota 55905, USA
    J Am Geriatr Soc 50:1644-50. 2002
    ..To compare persons with and without hip fracture for subsequent mortality and change in disability and nursing home (NH) use...
  27. ncbi request reprint Differences in atherosclerotic coronary heart disease between subjects with and without rheumatoid arthritis
    Marie Christine Aubry
    Divisions of Anatomic Pathology, Health Science Research, Biostatistics, and Rheumatology, Mayo Clinic, Rochester, Minnesota 55905, USA
    J Rheumatol 34:937-42. 2007
    ..Patients with rheumatoid arthritis (RA) are at increased risk for cardiovascular diseases (CVD). We compared the histologic features of coronary artery disease in patients with RA and non-RA controls...
  28. ncbi request reprint Primer: Demystifying risk--understanding and communicating medical risks
    Cynthia S Crowson
    Department of Health Sciences Research, all at the Mayo Clinic, Rochester, MN 55905, USA
    Nat Clin Pract Rheumatol 3:181-7; quiz 1 p following 187. 2007
    ..In the face of uncertainty, making a provisional decision with a plan to review it later can be a good strategy. Verifying the patient's comprehension can help ensure that the decisions reached are informed and acceptable...
  29. ncbi request reprint Frequency of infection in patients with rheumatoid arthritis compared with controls: a population-based study
    Michele F Doran
    Mayo Clinic, Rochester, Minnesota 55905, USA
    Arthritis Rheum 46:2287-93. 2002
    ..This retrospective longitudinal cohort study was undertaken to compare the frequency of infections in a population-based incidence cohort of RA patients with that in a group of individuals without RA from the same population...
  30. pmc Epidemiology and clinical characteristics of Beh├žet's disease in the US: a population-based study
    Kenneth T Calamia
    College of Medicine, Mayo Clinic, Jacksonville, FL, USA
    Arthritis Rheum 61:600-4. 2009
    ..Although well-documented in Eastern populations, epidemiologic data is scarce in North American countries. Here we describe the incidence and prevalence of BD in Olmsted County, Minnesota over 45 years...
  31. ncbi request reprint Patient, disease, and therapy-related factors that influence discontinuation of disease-modifying antirheumatic drugs: a population-based incidence cohort of patients with rheumatoid arthritis
    Hilal Maradit-Kremers
    Department of Health Sciences Research, Mayo Clinic, Rochester, MN 55905, USA
    J Rheumatol 33:248-55. 2006
    ..Our objective was to identify the predictors of DMARD discontinuation in an incidence cohort of patients with RA followed continuously from their incidence date...
  32. ncbi request reprint Glucocorticoids and cardiovascular events in rheumatoid arthritis: a population-based cohort study
    John M Davis
    Mayo Clinic, Rochester, Minnesota 55905, USA
    Arthritis Rheum 56:820-30. 2007
    ..To determine the relationship between glucocorticoid exposure and cardiovascular (CV) events in patients with rheumatoid arthritis (RA)...
  33. pmc Increased risk of peripheral arterial disease in polymyalgia rheumatica: a population-based cohort study
    Kenneth J Warrington
    Department of Medicine, Division of Rheumatology, Mayo Clinic, Rochester, MN 55905, USA
    Arthritis Res Ther 11:R50. 2009
    ..The present study was conducted to determine whether patients with polymyalgia rheumatica (PMR) are at an increased risk of peripheral arterial disease (PAD)...
  34. pmc Cancer preceding giant cell arteritis: a case-control study
    Tanaz A Kermani
    Mayo Clinic, Rochester, Minnesota 55905, USA
    Arthritis Rheum 62:1763-9. 2010
    ..To study the association between previous cancer and giant cell arteritis (GCA)...
  35. ncbi request reprint Risk factors for the development of psoriatic arthritis: a population based nested case control study
    Julian Thumboo
    Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota 55905, USA
    J Rheumatol 29:757-62. 2002
    ..To identify factors influencing the development of psoriatic arthritis (PsA) in a population-based, inception cohort of psoriasis (PS) patients...
  36. ncbi request reprint Determinants of patient satisfaction in chronic illness
    Michelle Bidaut-Russell
    Mayo Clinic, Rochester, Minnesota 55905, USA
    Arthritis Rheum 47:494-500. 2002
    ..To determine whether primary care provided by generalists versus subspecialists resulted in different levels of patient satisfaction among persons with chronic illness...
  37. doi request reprint Lack of association of high body mass index with risk for developing polymyalgia rheumatica
    Deana D Hoganson
    Division of Rheumatology, Mayo Clinic, Rochester, MN 55905, USA
    Int J Rheum Dis 13:e1-5. 2010
    ..Objectives: To determine the association between BMI and polymyalgia rheumatica (PMR) as well as the influence of BMI on glucocorticoid treatment duration and development of giant-cell arteritis (GCA) in patients with PMR...
  38. ncbi request reprint Preventive medical services among patients with rheumatoid arthritis
    Hilal Maradit Kremers
    Department of Health Sciences Research, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
    J Rheumatol 30:1940-7. 2003
    ....
  39. pmc The Rochester Epidemiology Project: exploiting the capabilities for population-based research in rheumatic diseases
    Hilal Maradit Kremers
    Department of Health Sciences Research, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
    Rheumatology (Oxford) 50:6-15. 2011
    ....
  40. pmc Analysis of complex biomarkers for human immune-mediated disorders based on cytokine responsiveness of peripheral blood cells
    John M Davis
    Division of Rheumatology, Department of Medicine, College of Medicine, Mayo Clinic, Rochester, MN 55905, USA
    J Immunol 184:7297-304. 2010
    ..Thus, our approach lays the foundation for the development of immunologic "signatures" that could be useful in predicting disease course and monitoring the outcomes of therapy among patients with immune-mediated diseases...
  41. pmc Malignancy risk in patients with giant cell arteritis: a population-based cohort study
    Tanaz A Kermani
    Mayo Clinic, Rochester, Minnesota 55905, USA
    Arthritis Care Res (Hoboken) 62:149-54. 2010
    ..To determine the incidence of cancer in a population-based cohort of patients with giant cell arteritis (GCA) compared with age- and sex-matched referent subjects...
  42. ncbi request reprint B-Lymphocytes in plaque and adventitia of coronary arteries in two patients with rheumatoid arthritis and coronary atherosclerosis: preliminary observations
    Marie Christine Aubry
    Division of Anatomic Pathology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
    Cardiovasc Pathol 13:233-6. 2004
    ..To describe the subtypes of lymphocytes in coronary arteries of two patients with rheumatoid arthritis (RA) and coronary artery disease (CAD)...
  43. doi request reprint Incidence and mortality of interstitial lung disease in rheumatoid arthritis: a population-based study
    Tim Bongartz
    Rheumatology Department, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA
    Arthritis Rheum 62:1583-91. 2010
    ..Interstitial lung disease (ILD) has been recognized as an important comorbidity in rheumatoid arthritis (RA). We undertook the current study to assess incidence, predictors, and mortality of RA-associated ILD...
  44. ncbi request reprint Short-term outcomes of acute knee injuries: does the provider make a difference?
    Peter C Amadio
    Mayo Clinic and Mayo Foundation, Rochester, Minnesota 55905, USA
    Arthritis Rheum 47:361-5. 2002
    ..To compare the short-term outcomes of acute knee injuries treated by specialists and generalists...
  45. pmc Cardiovascular morbidity and mortality in rheumatoid arthritis
    Sherine E Gabriel
    Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota 55905, USA
    Am J Med 121:S9-14. 2008
    ....
  46. pmc Systemic lupus erythematosus features in rheumatoid arthritis and their effect on overall mortality
    Murat Icen
    Department of Health Sciences Research, Mayo Foundation, 200 First St SW, Rochester, MN 55905, USA
    J Rheumatol 36:50-7. 2009
    ..However, their frequency and clinical significance are uncertain. We examined the frequency of SLE features in RA and their effect on overall mortality...
  47. ncbi request reprint Trends in the incidence of polymyalgia rheumatica over a 30 year period in Olmsted County, Minnesota, USA
    Michele F Doran
    Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota 55905, USA
    J Rheumatol 29:1694-7. 2002
    ..To determine time trends in the incidence and survival of polymyalgia rheumatica (PMR) over a 30 year period in Olmsted County, Minnesota, USA...
  48. ncbi request reprint How much of the increased incidence of heart failure in rheumatoid arthritis is attributable to traditional cardiovascular risk factors and ischemic heart disease?
    Cynthia S Crowson
    Mayo Clinic, Rochester, Minnesota 55905, USA
    Arthritis Rheum 52:3039-44. 2005
    ....
  49. ncbi request reprint The risk of congestive heart failure in rheumatoid arthritis: a population-based study over 46 years
    Paulo J Nicola
    Mayo Clinic, Rochester, Minnesota 55905, USA
    Arthritis Rheum 52:412-20. 2005
    ..We examined the risk and determinants of congestive heart failure (CHF) in patients with RA...
  50. ncbi request reprint Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study
    Hilal Maradit-Kremers
    Mayo Clinic, Rochester, Minnesota 55905, USA
    Arthritis Rheum 52:402-11. 2005
    ....
  51. pmc Do rheumatoid arthritis patients have a higher risk for sleep apnea?
    Stephanie R Reading
    Department of Health Sciences Research, Division of Epidemiology, Mayo Foundation, Rochester, MN 55905, USA
    J Rheumatol 36:1869-72. 2009
    ..The development of CVD has also been linked to chronic sleep apnea. The purpose of this study was to examine the risk for sleep apnea in patients with RA compared to subjects without RA...
  52. ncbi request reprint Epidemiology of gout: is the incidence rising?
    Emvalee Arromdee
    Division of Rheumatology, Mayo Clinic, Rochester, Minnesota 55905, USA
    J Rheumatol 29:2403-6. 2002
    ..To determine whether the incidence of gout is higher in 1995-1996 compared to 1977-1978...
  53. pmc The impact of gender, age, and preoperative pain severity on pain after TKA
    Jasvinder A Singh
    Department of Health Sciences Research, Mayo Clinic School of Medicine, Rochester, MN, USA
    Clin Orthop Relat Res 466:2717-23. 2008
    ..LEVEL OF EVIDENCE: Level II, prognostic study. See the Guidelines for Authors for a complete description of levels of evidence...
  54. ncbi request reprint Contribution of congestive heart failure and ischemic heart disease to excess mortality in rheumatoid arthritis
    Paulo J Nicola
    Dept of Health Sciences Research, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905, USA
    Arthritis Rheum 54:60-7. 2006
    ....
  55. doi request reprint Epidemiology of rheumatoid arthritis: rheumatoid arthritis and mortality
    Elena Myasoedova
    Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA
    Curr Rheumatol Rep 12:379-85. 2010
    ..In this review, we summarize the current knowledge of the rates and determinants of mortality in RA, identify and discuss potential explanations for excess mortality, and outline promising research avenues for targeting mortality in RA...
  56. ncbi request reprint Relapse in a population based cohort of patients with polymyalgia rheumatica
    Hilal Maradit Kremers
    Division of Epidemiology, Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota 55905, USA
    J Rheumatol 32:65-73. 2005
    ..To determine the incidence and the clinical, laboratory, and treatment related predictors of relapse in polymyalgia rheumatica (PMR)...
  57. ncbi request reprint Osteoporosis intervention following distal forearm fractures: a missed opportunity?
    Maria Teresa Cuddihy
    Division of Area General Internal Medicine, Department of Internal Medicine, Mayo Clinic and Foundation, 200 First St SW, Rochester, MN 55905, USA
    Arch Intern Med 162:421-6. 2002
    ..Fractures are a manifestation of osteoporosis, but therapeutic interventions to reduce the risk of recurrent fractures are not widespread...
  58. ncbi request reprint Use of physician services in a population-based cohort of patients with polymyalgia rheumatica over the course of their disease
    Hilal Maradit Kremers
    Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA
    Arthritis Rheum 53:395-403. 2005
    ..To describe the use of generalist and rheumatologist services in a population-based cohort of patients with polymyalgia rheumatica (PMR) and to identify predictors of rheumatology care...
  59. ncbi request reprint Direct medical costs of polymyalgia rheumatica
    Hilal Maradit Kremers
    Mayo Clinic, Rochester, Minnesota 55905, USA
    Arthritis Rheum 53:578-84. 2005
    ....
  60. ncbi request reprint Heart disease in rheumatoid arthritis: changing the paradigm of systemic inflammatory disorders
    Sherine Gabriel
    Department of Health Sciences Research, Mayo Clinic, 200 First Street SW, Rochester, Minnesota 55905, USA
    J Rheumatol 34:220-3. 2007
  61. pmc Potential misclassification of patients with psoriasis in electronic databases
    Murat Icen
    Department of Health Sciences Research, College of Medicine, Mayo Clinic, Rochester, Minnesota 55905, USA
    J Am Acad Dermatol 59:981-5. 2008
    ..Electronic claims and medical record databases are increasingly used for observational studies of psoriasis. The purpose of this study was to assess the validity of psoriasis diagnostic codes in an electronic database...
  62. ncbi request reprint Glucocorticoid therapy in giant cell arteritis: duration and adverse outcomes
    Anne Proven
    Mayo Clinic and Mayo Foundation, Rochester, Minnesota 55905, USA
    Arthritis Rheum 49:703-8. 2003
    ..To evaluate the course of glucocorticoid (GC) therapy and associated adverse events in a population-based cohort of patients with giant cell arteritis (GCA)...
  63. pmc Increased prevalence of diastolic dysfunction in rheumatoid arthritis
    Kimberly P Liang
    Department of Health Sciences Research, Mayo Clinic, Mayo Clinic College of Medicine, 200 First Street SW, Rochester MN 55905, USA
    Ann Rheum Dis 69:1665-70. 2010
    ....
  64. ncbi request reprint Rochester Epidemiology Project: a unique resource for research in the rheumatic diseases
    Hilal Maradit Kremers
    Division of Epidemiology, Department of Health Sciences Research, Mayo Clinic College of Medicine, 200 First Street Southwest, Rochester, MN 55905, USA
    Rheum Dis Clin North Am 30:819-34, vii. 2004
    ..This article describes the REP and highlights its research capabilities in the context of the rheumatic diseases...
  65. pmc Could accelerated aging explain the excess mortality in patients with seropositive rheumatoid arthritis?
    Cynthia S Crowson
    Mayo Clinic, Rochester, MN, USA
    Arthritis Rheum 62:378-82. 2010
    ....
  66. ncbi request reprint Rheumatoid arthritis and the heart
    Hilal Maradit Kremers
    Department of Health Sciences Research, Mayo Clinic, Rochester, MN 55905, USA
    Curr Heart Fail Rep 3:57-63. 2006
    ..This review provides an overview of the clinical studies that demonstrate increased risk of coronary heart disease and heart failure in patients with RA and also discusses the potential role of the various risk factors...
  67. pmc The influence of rheumatoid arthritis disease characteristics on heart failure
    Elena Myasoedova
    Mayo Clinic, Rochester, MN 55905, USA
    J Rheumatol 38:1601-6. 2011
    ..To examine the influence of rheumatoid arthritis (RA) characteristics and antirheumatic medications on the risk of heart failure (HF) in patients with RA...
  68. pmc Lipid paradox in rheumatoid arthritis: the impact of serum lipid measures and systemic inflammation on the risk of cardiovascular disease
    Elena Myasoedova
    Correspondence to Dr Sherine E Gabriel, Department of Health Sciences Research, Mayo Foundation, 200 First Street SW, Rochester, MN 55905, USA
    Ann Rheum Dis 70:482-7. 2011
    ..To examine the impact of systemic inflammation and serum lipids on cardiovascular disease (CVD) in rheumatoid arthritis (RA)...
  69. ncbi request reprint Posttransplantation diabetes: a systematic review of the literature
    Victor M Montori
    Division of Endocrinology, Diabetes, Metabolism, Nutrition, and Internal Medicine, Mayo Clinic, Rochester, Minnesota 55905, USA
    Diabetes Care 25:583-92. 2002
    ..To systematically review the incidence of posttransplantation diabetes (PTD), risk factors for its development, prognostic implications, and optimal management...
  70. ncbi request reprint A prospective clinical practice intervention to improve osteoporosis management following distal forearm fracture
    Maria Teresa Cuddihy
    Division of General Internal Medicine Area, Department of Internal Medicine, Mayo Clinic and Mayo Foundation, Rochester, Minnesota, USA
    Osteoporos Int 15:695-700. 2004
    ..Further initiatives are needed to overcome both system and patient barriers...
  71. ncbi request reprint Occurrence of extraarticular disease manifestations is associated with excess mortality in a community based cohort of patients with rheumatoid arthritis
    Carl Turesson
    Department of Rheumatology, Malmo University Hospital, Sweden
    J Rheumatol 29:62-7. 2002
    ..To investigate the occurrence of extraarticular manifestations (ExRA) in a well defined community based cohort of patients with rheumatoid arthritis (RA), and to examine their effect on mortality...
  72. ncbi request reprint Predictors of infection in rheumatoid arthritis
    Michele F Doran
    Beaumont Hospital, Dublin, Ireland
    Arthritis Rheum 46:2294-300. 2002
    ..This study was undertaken to identify predictors of serious infections among patients with RA. Identification of such factors is the necessary first step in reducing the excess risk of infection in RA...
  73. ncbi request reprint Economic evaluation of programs or interventions in the management of rheumatoid arthritis: defining a consensus-based reference case
    Andreas Maetzel
    Division of Clinical Decision Making and Health Care Research, Toronto General Research Institute, University Health Network, Toronto, Ontario, Canada
    J Rheumatol 30:891-6. 2003
    ..We provide the rationale for each element and discuss how each element has been addressed in published economic evaluations of DMARD...
  74. ncbi request reprint A population based assessment of the use of orthopedic surgery in patients with rheumatoid arthritis
    Loreto Massardo
    Department of Clinical Immunology and Rheumatology, Catholic University of Chile, Santiago
    J Rheumatol 29:52-6. 2002
    ..To describe the use of orthopedic surgery, including joint replacement surgery, in a well defined population based cohort of patients with rheumatoid arthritis (RA) and to identify characteristics that predict such use...
  75. ncbi request reprint Reappraisal of the epidemiology of giant cell arteritis in Olmsted County, Minnesota, over a fifty-year period
    Carlo Salvarani
    Arcispedale S Maria Nuova, Reggio Emilia, Italy
    Arthritis Rheum 51:264-8. 2004
    ..To investigate time trends in the incidence and survival of giant cell arteritis (GCA) over a 50-year period in Olmsted County, Minnesota...
  76. ncbi request reprint Use of low-dose glucocorticoids and the risk of cardiovascular morbidity and mortality in rheumatoid arthritis: what is the true direction of effect?
    John M Davis
    J Rheumatol 32:1856-62. 2005
  77. ncbi request reprint Osteopenia in adults with a history of juvenile rheumatoid arthritis. A population based study
    Anthony R French
    St Louis Children s Hospital, Washington University, Missouri, USA
    J Rheumatol 29:1065-70. 2002
    ..To determine the extent of osteopenia in a population based cohort of adults with a history of juvenile rheumatoid arthritis (JRA)...
  78. ncbi request reprint The cost-effectiveness of acetaminophen, NSAIDs, and selective COX-2 inhibitors in the treatment of symptomatic knee osteoarthritis
    Celia C Kamath
    Department of Health Sciences Research, Mayo Clinic, Rochester, MN 55905, USA
    Value Health 6:144-57. 2003
    ..The objective of this study was to conduct an economic evaluation of rofecoxib and celecoxib compared with high-dose acetaminophen or ibuprofen with and without misoprostol for patients with symptomatic knee osteoarthritis (OA)...
  79. ncbi request reprint The need for microsimulation to evaluate osteoporosis interventions
    David J Vanness
    Department of Population Health Sciences, University of Wisconsin Medical School, Madison, WI 53726, USA
    Osteoporos Int 16:353-8. 2005
    ..However, evaluations based on structural microsimulation may ultimately provide substantially more useful information, resulting in improved decision making...
  80. ncbi request reprint Tumor necrosis factor inhibition: a part of the solution or a part of the problem of heart failure in rheumatoid arthritis?
    Sherine E Gabriel
    Arthritis Rheum 58:637-40. 2008
  81. ncbi request reprint A call for evidence-based quality measures: a goal worthy of pursuit
    Daniel H Solomon
    Nat Clin Pract Rheumatol 3:363. 2007
  82. ncbi request reprint Reading and interpreting economic evaluations in rheumatoid arthritis: an assessment of selected instruments for critical appraisal
    Michael H Weisman
    Evidence Based Medicine Working Groups in Rheumatology, Beverly Hills, CA, USA
    J Rheumatol 30:1739-47. 2003
    ..To describe and compare the relative attributes (reliability, ease of use, applicability, and relevance) of different assessment tools for economic analyses as they pertain to rheumatoid arthritis (RA) literature...
  83. ncbi request reprint Autoantibodies: innocent bystander or key player in immunosenescence and atherosclerosis?
    Kimberly P Liang
    J Rheumatol 34:1203-7. 2007
  84. ncbi request reprint The effect of oral contraceptives and estrogen replacement therapy on the risk of rheumatoid arthritis: a population based study
    Michele F Doran
    Department of Rheumatology, Mater Misericordiae University Hospital, Dublin, Ireland
    J Rheumatol 31:207-13. 2004
    ..We examined whether exposure to either oral contraceptives (OC) or postmenopausal estrogen replacement therapy (ERT) is associated with the development of RA in women...

Research Grants9

  1. HEART DISEASE IN RHEUMATOID ARTHRITIS
    Sherine Gabriel; Fiscal Year: 2004
    ....
  2. HEART DISEASE IN RHEUMATOID ARTHRITIS
    Sherine E Gabriel; Fiscal Year: 2010
    ..We will use echocardiograms, and tests of immunity in order to identify early signs of heart failure (in persons with Rheumatoid Arthritis) at a time when it may be treatable. ..
  3. HEART DISEASE IN RHEUMATOID ARTHRITIS
    Sherine Gabriel; Fiscal Year: 2007
    ..We will use echocardiograms, and tests of immunity in order to identify early signs of heart failure (in persons with Rheumatoid Arthritis) at a time when it may be treatable. ..
  4. HEART DISEASE IN RHEUMATOID ARTHRITIS
    Sherine Gabriel; Fiscal Year: 2009
    ..We will use echocardiograms, and tests of immunity in order to identify early signs of heart failure (in persons with Rheumatoid Arthritis) at a time when it may be treatable. ..